Corticosteroid insensitivity in severe asthma: Impaired nuclear translocation of glucocorticoid receptor in airway smooth muscle cells Source: Annual Congress 2012 - Cellular signalling mechanisms in the airways Year: 2012
Activated protein phosphatase PP2A by formoterol enhances nuclear translocation of glucocorticoid receptor induced by budesonide Source: Annual Congress 2011 - Models of disease and drug actions Year: 2011
Glucocorticoid receptor-binding characteristics in severe asthma Source: Eur Respir J 2003; 21: 985-988 Year: 2003
The CysLT1 receptor antagonist montelukast inhibits mast cell activation induced by inhaled leukotriene E4 in subjects with asthma Source: International Congress 2016 – Clinical and molecular studies in asthma Year: 2016
Salmeterol response is not affected by beta2 -adrenergic receptor genotype in patients with persistent asthma Source: Eur Respir J 2005; 26: Suppl. 49, 505s Year: 2005
Expression of the glucocorticoid β receptor in the sputum of moderate and severe asthmatics Source: Eur Respir J 2003; 22: Suppl. 45, 412s Year: 2003
Lack of glucocorticoid receptor activation by formoterol and salmeterol in human bronchial epithelial cells Source: Eur Respir J 2003; 22: Suppl. 45, 454s Year: 2003
Bronchial thermoplasty may increase steroid sensitivity by upregulating the expression of the glucocorticoid receptor Source: Virtual Congress 2020 – Asthma pharmacology: clinical trials and mechanistic insights Year: 2020
Formoterol restores corticosteroid responses in corticosteroid-insensitive severe asthma Source: Eur Respir J 2005; 26: Suppl. 49, 50s Year: 2005
An inhaled IGFBP-3 peptide attenuates steroid-resistant neutrophilic bronchial asthma through modulation of ER stress Source: International Congress 2019 – Novel targets and mechanisms in asthma Year: 2019
Importin-7 knockdown reduces corticosteroid induced glucocorticoid receptor nuclear localisation and suppression of IL-1beta induced CXCL8 Source: Annual Congress 2013 –Novel mechanisms for established drugs for asthma and COPD management Year: 2013
Rhinovirus infection reduces glucocorticoid receptor nuclear translocation in airway epithelial cells Source: Annual Congress 2003 - Acute exacerbations of asthma and COPD Year: 2003
The glucocorticoid nuclear action peculiarities in the steroid-resistant patients with severe bronchial asthma Source: Eur Respir J 2003; 22: Suppl. 45, 32s Year: 2003
A fully dissociated glucocorticoid receptor modulator reduces airway hyperresponsiveness and inflammation in a murine model of asthma Source: Annual Congress 2010 - Pre-clinical models of airways disease Year: 2010
Effect of leukotriene receptor antagonist on expression and variation of TGF-beta in T lymphocyte for mild persistent asthma in children Source: Annual Congress 2011 - Treating childhood asthma Year: 2011
Airway neutrophils have reduced glucocorticoid receptor expression Source: Annual Congress 2008 - Recent advances in the pathogenesis and treatment of asthma and COPD Year: 2008
The CysLT1 receptor antagonist montelukast blocks bronchoconstriction induced by inhaled leukotriene E4 in subjects with asthma Source: International Congress 2015 – The immunology of allergic airway disease Year: 2015
The role of glucocorticoid receptor a and ß isoforms in exacerbations of asthma, COPD, and ACOS Source: International Congress 2017 – Gene signatures in bronchial diseases Year: 2017
Fluticasone furoate, a novel corticosteroid, maintains glucocorticoid receptor nuclear localisation for 24 hours after washout in monocytes Source: Annual Congress 2011 - Translational models of disease Year: 2011
Inhaled PPAR-r agonist inhibit the airway inflammation in murine model of acute and chronic asthma Source: Eur Respir J 2007; 30: Suppl. 51, 24s Year: 2007